Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

NCT07022457

Conditions
Melanoma, Metastatic Melanoma, BRAF V600 Mutation Positive, Neoplasms, +10 more
Locations
  • Southend University Hospital Westcliff-on-Sea, Essex, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
  • University Hospital Coventry and Warwickshire Coventry, United Kingdom
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

Conditions
Adenocarcinoma, Adnexal Diseases, Anal Cancer, +85 more
Locations
  • St. Vincent's Private Hospital Darlinghurst, New South Wales, Australia
  • Mater Misericordiae Ltd. Brisbane, Queensland, Australia
  • Tasman Oncology Research Southport, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View Trial Details
Active, Not Recruiting

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

NCT06101134

Conditions
Behavior, Health Behavior, Melanoma, +18 more
Locations
  • Local Institution - 0007 Anchorage, Alaska, United States
  • Local Institution - 0013 Phoenix, Arizona, United States
  • Local Institution - 0010 San Francisco, California, United States
  • Local Institution - 0034 Atlanta, Georgia, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

NCT06099782

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations
  • Russell Medical ( Site 0160) Alexander City, Alabama, United States
  • Alaska Oncology and Hematology ( Site 0121) Anchorage, Alaska, United States
  • Highlands Oncology Group-Research Department ( Site 0133) Springdale, Arkansas, United States
  • Marin Cancer Care ( Site 0148) Greenbrae, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma

NCT04657991

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Adventist Health System/Sunbelt, Inc. Orlando, Florida, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • AdventHealth Orlando Infusion Center Orlando, Florida, United States
  • AdventHealth Orlando, Investigational Drug Services Orlando, Florida, United States
View all 143 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details

Related conditions